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Abstract The construction and characterization of a core
kinetic model of the glucose-stimulated insulin secretion
system (GSIS) in pancreatic b cells is described. The model
consists of 44 enzymatic reactions, 59 metabolic state
variables, and 272 parameters. It integrates ﬁve subsys-
tems: glycolysis, the TCA cycle, the respiratory chain,
NADH shuttles, and the pyruvate cycle. It also takes into
account compartmentalization of the reactions in the
cytoplasm and mitochondrial matrix. The model shows
expected behavior in its outputs, including the response of
ATP production to starting glucose concentration and the
induction of oscillations of metabolite concentrations in the
glycolytic pathway and in ATP and ADP concentrations.
Identiﬁcation of choke points and parameter sensitivity
analysis indicate that the glycolytic pathway, and to a
lesser extent the TCA cycle, are critical to the proper
behavior of the system, while parameters in other compo-
nents such as the respiratory chain are less critical. Nota-
bly, however, sensitivity analysis identiﬁes the ﬁrst
reactions of nonglycolytic pathways as being important for
the behavior of the system. The model is robust to deletion
of malic enzyme activity, which is absent in mouse pan-
creatic b cells. The model represents a step toward the
construction of a model with species-speciﬁc parameters
that can be used to understand mouse models of diabetes
and the relationship of these mouse models to the human
disease state.
Introduction
Type 2 diabetes mellitus (T2DM), along with associated
problems such as hypertension, dyslipidemias, and obesity,
is an increasing problem in human populations: 150 million
individuals are currently affected and a rapid expansion is
expected during the next 20 years (Freeman and Cox 2006).
Human genetic studies provide strong evidence that predis-
position to T2DM, and in particular its deﬁning phenotype,
glucose intolerance, has a complex genetic basis (McCarthy
2004). This is supported by studies in animal models. A
signiﬁcant number of candidate genes for involvement in
predisposition to T2DM are implicated in pancreatic b-cell
dysfunction (Freeman and Cox 2006). Glucose-stimulated
insulinsecretion(GSIS)isthepivotalhomeostaticprocessin
the control of blood glucose levels and takes place in pan-
creaticbcells(AshcroftandRorsman2004).GSIStakesina
number of relatively well characterized biochemical path-
ways such as glycolysis, the TCA cycle, and the respiratory
chain (Fig. 1A), but new discoveries implicate novel fea-
tures of b-cell biochemistry (Eto et al. 1999; Newgard et al.
2002; Ronnebaum et al. 2006; Rubi et al. 2004). The effects
of individual mutations on the GSIS system are not always
intuitively obvious and qualitative descriptions do not allow
for a quantitative analysis of these effects. It should be
possible to overcome these problems by building explicit
mathematical models of the system.
Systems biology aims at system-level understanding of
biological processes and how a system’s behavior emerges
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milestone for successful cell simulation might be the con-
struction of a whole metabolic model. Consequently, bio-
chemical dynamic models composed of a relatively large
number of metabolic reactions are being developed.
Examples are models of central carbon metabolism in
E. coli (Chassagnole et al. 2002; Varner 2000), glycolysis in
lactic acid bacteria (Hoefnagel et al. 2002), mitochondrial
Fig. 1 Pathways involved in GSIS. A Diagrammatic representation
of processes linking glucose uptake to insulin secretion in pancreatic
b cells. The diagram represents processes taking place in the presence
of extracellular glucose. Glucose is imported into the b cell and
undergoes glycolysis. The primary product of glycolysis is pyruvate,
which is imported into mitochondria. Malate, an intermediate product
of glycolysis and NADH, also a product of this pathway, may also be
imported into mitochondria via the NADH shuttles. Malate is
converted to fumarate, which is also a product of the TCA cycle
fed by pyruvate and is a substrate of the respiratory chain, whose end
product is ATP. Imported NADH can also feed into the respiratory
chain. Pyruvate may also be recycled from the mitochondrial matrix
to the cytoplasm via the pyruvate cycling pathway. ATP interacts
with the KATP channel to block it, resulting in an increase in
intracellular K
+ and depolarization of the cell membrane. This in turn
leads to activation of the voltage-gated Ca
2+ channel, inﬂux of Ca
2+,
and activation of insulin granule exocytosis. B Overview of the
kinetic network modeled. Reactions are represented as arrows (which
may be uni- or bidirectional) and labeled v1 to v44. Metabolites,
which are transformed by the reactions, are labeled according to their
cellular location: metabolites in the cytoplasm and intermembrane
space are labeled in blue, and metabolites in the mitochondrial matrix
are labeled in black. Enzymes catalyzing reactions are labeled in
brown. Abbreviations are as in Table 1
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123NADH shuttles and anaplerosis in b cells (Westermark et al.
2006), and mitochondrial ATP production (Bertram et al.
2006; Magnus and Keizer 1997, 1998a, 1998b). The
advantage of such detailed, biochemically formulated
models is that a one-to-one comparison can be made be-
tween model and experiment. Thus, they provide platforms
that allow discovery of new intrinsic biological properties.
A number of mathematical and computational models
have been developed related to the GSIS system. Topp
et al. (2000) designed a model that includes three ordinary
differential equations (ODEs) representing the dynamics of
glucose and insulin within the mass of b cells. As a coarse-
grid model, the model concentrates on investigating the
normal behavior of the glucose regulatory system and
pathways into diabetes. Another minimal model was
developed by Bertram et al. (2006). They built a simpliﬁed
ATP synthesis model based on earlier models of oxidative
phosphorylation (Magnus and Keizer 1997, 1998a, 1998b)
to capture the same behavior as in Magnus and Keizer’s
models. In the Bertram et al. model, they took pyruvate as
the main input of their system and ATP as the end product.
Four mitochondrial variables (NADHm, ADPm, DW, and
Cam) are described with equations corresponding to the
dynamics of different types of ﬂuxes or reactions. With
their simpliﬁed model they investigated the dynamics of
the four mitochondrial variables versus the change of
glycolytic ﬂux and pulses of calcium. A more reﬁned
simulation model for the mitochondrial system was
developed by Yugi and Tomita (2004). In this model 58
enzymatic reactions and 117 metabolites are included to
represent four pathways (respiratory chain, the TCA cycle,
fatty acid b oxidation, and the inner-membrane transport
system) in mitochondria. Previously published enzyme
kinetics studies from the literature were integrated into a
single dynamic model using the E-cell2 simulation plat-
form (http://www.e-cell.org).
Following recent research on the importance of NADH
shuttles in ATP production, a mathematical model of
mitochondrial NADH shuttles has been developed by
Westermark et al. (2006). The model comprises the mito-
chondrial NADH shuttles and mitochondrial metabolism,
which in total included 19 enzyme reactions and 10
metabolites with simpliﬁcations on the boundary of the
system. The model reproduces the experimental ﬁnding by
Eto et al. (1999) that blocking the NADH shuttles attenu-
ates the signaling to ATP production while retaining the
rate of glucose oxidation. Besides the model of NADH
shuttles, Westermark and Lansner (2003) also constructed
a model of the upper part of glycolysis in the pancreatic b
cell. The model concentrated on studies on the enzymatic
reactions of PFK (phosphofructokinase), which has been
shown to control metabolite oscillations in the glycolysis
pathway. Although more and more computational dynamic
models have been constructed, a complete, detailed kinetic
model with a large number of enzyme rate equations
mimicking the dynamics from glucose input to ATP pro-
duction has not been developed so far.
We therefore initiated the development of a quantitative,
kinetic model of the core processes in GSIS as an aid to
understanding genetic and biochemical data in mouse
models of T2DM. Constructing such a model poses a sig-
niﬁcant technical and intellectual challenge because the
GSIS system consists of at least ﬁve biochemical sub-
pathways (glycolysis, TCA cycle, the respiratory chain,
NADH shuttles, and the pyruvate cycle) that take place in
more than one cellular compartment (cytoplasm and
mitochondrion). In addition, the system consists of a large
number of interacting metabolites and enzymes. Here we
describe a kinetic model of the pathways leading from the
beginning of glycolysis to ATP production, which we call
the core process. We show that the model has qualitative
properties consistent with expectations, including showing
oscillations in the glycolysis pathway and in ATP con-
centration. We also discuss some analyses of the properties
of the network and its applicability to mouse models and
the understanding of human disease.
Methods
We used mathematical modeling in which all metabolite
interactions are described in terms of kinetic equations.
The components of our mathematical model are kinetic
parameters and state variables, which indicate the state of a
system at a certain time. The kinetic parameters include
Michaelis-Menten constants, rate constants of association
and dissociation, etc. Most of the kinetic parameters were
taken from the literature (see Supplementary Materials).
Our model is based on ODEs and consists of 44 enzy-
matic reactions, 59 metabolic state variables, and 272
parameters. The number of parameters is large because
most of the rate equations inside the mitochondrion follow
complex reaction mechanisms (Ping-pong Bi Bi, Ordered
Bi Bi, etc.), although identical reactions in different com-
partments have been assumed to have the same parameters.
The following is a representative derivation of one of the
59 ODEs. To determine the change in the concentration of
a certain metabolite [mi] over time, we calculate the sum of
the reaction rates producing [mi] minus the rates consum-
ing [mi]. Thus, we get the following differential equation,
where i represents one of the 59 metabolites:
dm i ½ 
dt
¼
X
mproduction  
X
mconsumption
The simulation is then equivalent to solving the following
differential equations:
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dt
¼ ft ; mi ½  ; p ðÞ
mt 0 ðÞ ¼ m0 p ðÞ
in which p represents the parameters in the model.
Constructing the network
There is a growing appreciation of the complexity of the
pathways involved in GSIS from pancreatic b cells. Tra-
ditionally, it has been accepted that an increase in the ATP/
ADP ratio brought about by glucose ﬂux through glycolysis
and the tricarboxylic acid (TCA) cycle is central to the
GSIS. In addition, it has been demonstrated that the con-
tributions of the TCA cycle and NADH shuttle system to
mitochondrial ATP production may be approximately
equal (Eto et al. 1999; Rubi et al. 2004). Recently, the role
of cytosolic NADP-dependent isocitrate dehydrogenase
(ICDc) in control of GSIS in b cells has been studied
(Newgard et al. 2002; Ronnebaum et al. 2006). From these
studies it has been concluded that the pyruvate cycling
pathway involving ICDc plays an important role in the
control of GSIS. Therefore, in our model we included ﬁve
subpathways: glycolysis, the TCA cycle, the respiratory
chain, NADH shuttles and the pyruvate cycle, as shown in
Table 1 and Fig. 1B. Reactions represented by arrows in
Fig. 1B are speciﬁed in detail in the Supplementary
Materials. The molecular components (metabolites and
enzymes) of the model are shown in detail in Supple-
mentary Table 1. ATP is a natural point at which to sep-
arate these core metabolic processes from downstream
processes taking place at or near the cell membrane (KATP
channels, voltage-gated Ca
2+ channels, and insulin granule
exocytosis) because it integrates the outputs of the various
metabolic pathways.
Three compartments are considered in our model: the
mitochondrial matrix, mitochondrial intermembrane space,
and the cytoplasm surrounding the mitochondrion. All the
enzymatic reactions are represented by rate equations.
Cytoplasmic and mitochondrial pools of metabolite are
treated separately, as are cytoplasmic and mitochondrial
reactions. Table 1 contains details of cytoplasmic and
mitochondrial metabolites and associations of the various
reactions and metabolites with individual subpathways.
The reactions within the mitochondrion are based on the
work done by Yugi and Tomita (2004) (see their article for
references to original studies). Other reactions (Halestrap
1975; Matsuoka and Srere 1973;P a ˚hlman et al. 2002;
Swierczynski 1980) were collected from the SABIO-RK
database (http://www.sabio.villa-bosch.de/SABIORK/).
The initial metabolite concentrations are taken from the
literature. The matrix volume is set at 4.3 · 10
–16 in
correspondence to the Yugi-Tomita model. The volume of
cytoplasm is taken to be 6.5 · 10
–12 L.
The metabolite and enzyme concentrations, rate equa-
tions, and kinetic parameters were formulated and trans-
ferred into SBML (Systems Biology Markup language;
Hucka et al. 2004) for simulation. Simulations are per-
formed by CVODE solvers (SUNDIALS suite) (Hindmarsh
et al. 2005; Serban and Hindmarsh 2005) with Matlab
(Mathworks, Natick, MA) and the Systems Biology Tool-
box (Schmidt and Jirstrand 2006).
Because our initial set of parameters came from differ-
ent sources, we needed to make them all consistent in this
system. To do this we assumed the parameters within one
reaction to be constant, then we scaled the rate equations
appropriately.
Network analysis
Choke point analysis was performed using the Pathway
Hunter Tool (Rahman and Schomburg 2006) to identify the
enzymes or reactions that are crucial for the network. A
choke point is deﬁned as an enzyme or reaction that un-
iquely consumes and/or produces a certain metabolite.
Normally, the simulation results of a large-scale model
depend on various parameters, through the parameters of
rate equations and the initial conditions. Sensitivity anal-
ysis measures the sensitivity of the simulation results with
respect to the model parameters to estimate which
parameters are most inﬂuential in affecting the behavior of
the simulation. The solution of sensitivity with respect to
the model parameter pi is deﬁned as the vector
si t ðÞ¼
@mt ðÞ
@pi
and satisﬁes the following equations:
si ¼
@f
@m
si þ
@f
@pi
si t0 ðÞ ¼
@m0 p ðÞ
@pi
The outputs of the above partial equations are parameter
sensitivity trajectories (versus time). For each trajectory,
the bigger the changes the more the model simulation re-
sults are sensitive to the related pi and vice versa. We
calculated the sensitivity trajectories and scaled them into
0–1 (shown as a matrix) to show parameter sensitivities
versus simulation output of the model. Sensitivity analysis
was performed with the SBaddon package v1.1 and the
Systems Biology Toolbox (Schmidt and Jirstrand 2006) for
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123Table 1 Membership of subpathways in the model
Subpathway Reactions Enzymes Metabolites
Glycolysis
(cytoplasmic)
v1-v7 Glucokinase (GK) Glucose (GLC)
6-Phosphofructokinase (PFK) Fructose-6-phosphate (F6P)
Fructose-bisphosphate aldolase (FBA) ADP(cyt)
Glyceraldehyde 3-phosphate dehydrogenase (GAPD) ATP(cyt)
Bisphosphoglycerate phosphatase (PGP) Fructose-1,6-bisphosphate
(FBP)
Pyruvate kinase (PK) Glyceraldehyde 3-phosphate
(GAP)
Lactate dehydrogenase (LDH) 1,3-bisphospho-D-glycerate
(DPG)
NAD+(cyt)
NADH(cyt)
Phosphoenol pyruvate (PEP)
Pyruvate (PYR(cyt))
Lactate (LAC)
TCA cycle
(mitochondrial)
v9-v12, v14-v18, v23,v36 Pyruvate dehydrogenase complex (PDC) Carbon dioxide (CO2)
Citrate synthase (CS) Citrate (Cit)
Aconitase (ACO) Coenzyme A (CoA)
Isocitrate dehydrogenase (NAD+) (IDHa) Oxaloacetate (OXA)
Phosphate carrier (PiC) Acetyl_CoA
Oxoglutarate dehydrogenase complex (OGDC) Isocitrate (IsoCit)
Succinyl-CoA synthetase (SCS) Oxoglutarate (OG)
Succinate dehydrogenase (SDH) Phosphate (Pi)
Fumarase (FM) Succinyl-CoA (SCoA)
Malate dehydrogenase (MDH) Succinate (Suc)
Aspartate transaminase (AspTA) Guanosine diphosphate (GDP)
Nucleoside diphosphate kinase (NDK) Guanosine triphosphate (GTP)
Pyruvate carboxylase (PC) Fumarate (Fum)
Ubiquinone (Q)
Ubiquinol (QH2)
Malate (Mal)
Glutamate (Glu)
Aspartate (Asp)
ADP
ATP
PYR
Respiratory chain
(mitochondrial)
v24-v26, v28 Complex-I NAD+
Complex-III NADH
Complex-IV Q
Complex-V QH2
Ferricytochrome C (Cyt_c2+)
Ferrocytochrome C (Cyt_c3+)
Water (H2O)
ADP
ATP
Pi
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123Table 1 continued
Subpathway Reactions Enzymes Metabolites
NADH shuttles V16-v18, v20-v22, v30-v32,
v34-v35, v37-v38
FM NAD+
Alanine transaminase (AlaTA) NADH
SDH NAD+(cyt)
AspTA NADH(cyt)
Aspartate/glutamate carrier (AGC) OXA
Oxoglutarate carrier (OGC) OXA(cyt)
MDH OG
ETF:Q oxidoreductase (ETF-QO) OG(cyt)
Glutathione reductase (GSSGR) Q
Pyruvate carboxylase (PC) QH2
Glycerol-3-phosphate dehydrogenase
(FAD dependent) (GUT2P)
Mal
Glycerol-3-phosphate dehydrogenase (NAD+) (G3PD) Mal(cyt)
Glu
Glu(cyt)
Asp
Asp(cyt)
Electron Transfer Flavoprotein
(oxidized form) (ETF_ox)
Electron Transfer Flavoprotein
(reduced form) (ETF_red)
FAD
FADH2
Dihydroxyacetone-phosphate
(DHAP)
Glycerol-3-phosphate (G3P)
Fum
Suc
Pyruvate Cycle v10-v12, v18, v27, v29-v31,
v33, v36, v39, v41-v42, v44
CS NAD+
ACO NADH
IDHa NAD+(cyt)
OGC NADH(cyt)
PC Cit
Citrate carrier (CIC) Cit(cyt)
Malate dehydrogenase (oxaloacetatedecarboxylating) IsoCit
(NADP+) (ME) IsoCit(cyt)
Cytosolic isocitrate dehydrogenase (NADP+) (IDHc) Mal
MDH Mal(cyt)
NADP+
NADPH
NADP+(cyt)
NADPH(cyt)
Acetyl-CoA
Acetyl-CoA(cyt)
CoA
CoA(cyt)
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123Matlab, which was also used to perform correlation anal-
ysis. Correlation analysis calculates the correlated behavior
of parameters in the system during sensitivity analysis and
can be taken as an indication of concerted behavior, or
constraints, of reactions or reaction parameters.
Results
Performance analysis
The most basic dynamic property of the GSIS system is
oscillation along glycolysis (see Westermark and Lansner
2003) and the concentration relationship between ATP and
glucose (Detimary et al. 1996). Figure 2 shows dynamic
simulation results of some metabolites in the network. The
metabolites along the glycolysis pathway show the desired
oscillations. The metabolites outside the glycolysis path-
way (e.g., malate and citrate inside the mitochondrion) did
not show oscillations. ADP and ATP showed oscillations,
as required for stimulation of Ca
2+ transport in b cells
(Westermark and Lansner 2003). ATP concentration in-
creased with the change of glucose concentration from 0 to
20 mM, while ADP concentration decreased. Figure 3
shows the concentration change of ATP with changes of
glucose concentration. Consistent with the observations of
Detimary et al. (1996), the model predicts ATP levels to
increase more than twofold between 0 and 10 mM glucose
and then plateau. At 6 mM glucose, the ATP level was
1.78-fold higher than the initial state concentration. ADP
progressively decreased to 0 mM as glucose increased from
0 to 6 mM (data not shown). It should be noted that the
ATP concentrations predicted by the model represent an
upper bound on intracellular ATP concentration because
they do not take into account consumption of ATP by KATP
channel activity and other cellular processes.
Deletion of malate dehydrogenase
MacDonald (2002) reported that murine pancreatic islets do
not contain detectable levels of malic enzyme (malate
dehydrogenase; ME), whereas human and rat islets do. We
Table 1 continued
Subpathway Reactions Enzymes Metabolites
OXA
PYR
PYR(cyt)
ATP
ADP
Pi
CO2
Matabolite transport v8, v13, v19, v30, v33,
v40, v42-v43
Pyruvate Carrier (PYC) PYR (cyt)
Phosphate Carrier (PiC) PYR
Dicarboxyrate Carrier (DIC) Pi(IMS)
OGC Pi
CIC Mal
ATP/ADP Carrier (AAC) Mal(cyt)
Cit
Cit(cyt)
IsoCit
IsoCit(cyt)
OG
OG(cyt)
ATP
ATP(cyt)
ADP
ADP(cyt)
The table provides information on the reactions, enzymes, and metabolites associated with each of the subpathways included in the model.
Abbreviations used for enzymes and metabolites elsewhere in the article are given in parentheses. Cytoplasmic and metabolic metabolites are
distinguished where relevant.
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123therefore simulated the effect of removing ME from the
model. The model showed a 7.5% increase in cytoplasmic
malate concentration and a 9.6% decrease in pyruvate on
deletionofME,aswellassmalleffectsontheconcentrations
ofsomeothermetabolites(oftheorderof1%–2%).However
theresultantATPconcentrationwasnotsigniﬁcantlyaltered.
The oscillatory behavior of the model was also unaffected.
Network analysis
Choke point analysis
A choke point is deﬁned as a reaction that uniquely con-
sumes and/or produces a certain metabolite. Choke points
are critical points in networks (Yeh et al. 2004). In our
network inactivation of choke points may lead to a failure to
produce or consume particular metabolites that could cause
serious problems for ATP production. To detect choke
points we input the EC numbers of all enzymes in our
Fig. 2 Simulation results of the model. Plots of the variation in concentration of selected metabolites from a starting state with successive cycles
of the model. Concentrations are represented as molar concentrations. The x axis represents individual sequential states of the model
Fig. 3 Relationship of ATP with glucose. The graph shows the effect
of varying input glucose concentration on the ﬁnal ATP concentration
of the model after 500 cycles of modeling
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123network into the Pathway Hunter Tool (PHT; Rahman and
Schomburg 2006). Six enzymes were identiﬁed as choke
points: GK (E.C.2.7.1.2; glucokinase), PFK (E.C.2.7.1.11;
6-phosphofructokinase), FBA (E.C. 4.1.2.13; fructose bis-
phosphate aldolase), PGP (E.C.5.4.2.1/5.4.2.4; bisphos-
phoglycerate phosphatase), PK (E.C.2.7.1.40; pyruvate
kinase), and NDK (E.C.2.7.4.6; nucleoside diphosphate
kinase). Five of these are in the glycolysis pathway; we
therefore conclude that glycolysis is the most critical sub-
pathway for the functioning of the network.
Parameter space analysis
Because the glycolysis pathway is the critical pathway in
our system and shows oscillations, we calculated the
parameter ranges for oscillations in the pathway. The re-
sults are shown in Fig. 4. The oscillation behavior of the
pathway is sensitive to parameters of reactions v2, v5, and
v6. Thus, we predict that the enzymes PFK, PGP, and PK
have crucial inﬂuences on oscillation, whereas reaction v3
catalyzed by FBA is the most robust reaction.
Sensitivity and correlation analysis
With a detailed biochemically formulated model, it is
convenient to analyze the behavior of any metabolite of
interest within the system. However, for analysis of the
global properties of the system, the model could be sim-
pliﬁed. Sensitivity analysis-based methods can be used to
identify those parts of the model that are relatively unim-
portant for the properties of the system, and those parts
could be eliminated from the model (Dano et al. 2006).
Sensitivity analysis also provides an indication of the
biological realisticness of the model. We therefore per-
formed sensitivity analysis of the parameters along each
subpathway using SBaddon and the Systems Biology
Toolbox (Schmidt and Jirstrand 2006). Figure 5A shows
the analysis results for the glycolysis pathway. The rest of
the results are shown in the Supplementary Materials. We
can see that along the glycolysis pathway parameters in
reactions v1, v2, v6, and v8 have the most effect on the
state variables. Three reactions in the TCA cycle also
showed a high level of sensitivity: v9, v14, and v17. The
other subpathways in the model showed less sensitivity to
parameter changes than glycolysis. Typically, any sensi-
tivity observed lay at the beginning of a particular sub-
pathway. Thus, sensitivity was observed at reaction v9 at
the beginning of the TCA cycle (from the perspective of
incoming pyruvate), at reaction v17 in the NADH: malate
aspartate shuttle, which is the reaction consuming incom-
ing malate, at reaction v24 in the NADH:glycerophosphate
shuttle, which is the ﬁrst step of the respiratory chain, and
at reactions v41 and v44 of the pyruvate cycle.
Correlation analysis is based on the output from sensi-
tivity analysis and represents concerted behavior of
parameters in the system. Correlation analysis of glycolysis
(Fig. 5B) shows strong interreaction correlations between
most of the reactions in the pathway with the exception of
reaction v8 (pyruvate transport across the mitochondrial
membrane), which showed only self-correlation. Strong
cross-correlation was also observed in the pyruvate cycle.
In the other subpathways, particularly the TCA cycle and
NADH:malate aspartate shuttle, little evidence of correla-
tion was seen between reactions. However, correlation was
Fig. 4 Parameter space for oscillations (glycolysis pathway). The
plot represents ranges of individual parameters (represented as
relative values compared with those presented in Supplementary
Table 3) for which the model produced oscillations in the glycolysis
pathway. A complete list of modeling parameters with their origins is
provided in the Supplementary Materials
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reactions v28, v40, and v43 (import of ADP into the
mitochondrion, production of ATP by complex V, and its
export) and reactions v38 (the start of the NADH:glyc-
erophosphate shuttle, catalyzed by G3PD [glycerol-3-
phosphate dehydrogenase]) and v4 (catalyzed by GAPD
[glyceraldehyde-3-phosphate dehydrogenase]).
Discussion
In this article we describe a mathematical model of the core
dynamics of the glucose-stimulated insulin secretion
(GSIS) pathway of pancreatic b cells. This model draws on
a body of previous work on the modeling of the glycolysis
pathway (Nielsen et al. 1998) and mitochondrial metabo-
lism (Yugi and Tomita 2004 and references therein) but
brings in additional features, notably NADH shuttles and
the pyruvate cycle (Eto et al. 1999; Newgard et al. 2002;
Ronnebaum et al. 2006; Rubi et al. 2004), to provide a
more comprehensive view than has previously been
available. The model calculates the changes over time in
the concentration of 59 metabolites. We have assessed the
behavior of the model with respect to two core properties
of the GSIS system: (1) the relationship between ATP
output and glucose input concentrations and (2) oscillations
of metabolite concentration in the glycolysis pathway. By
measuring the nucleotide content of islets isolated from
NMR1 mice, Detimary et al. (1996) showed a twofold
increase in ATP content between 0 and 10 mM starting
glucose concentration, with a subsequent ﬂattening off of
the rate of increase. Our model shows the same pattern of
ATP concentration change (Fig. 3). Oscillations in the
glycolysis pathway are a well-established feature of the
system (Westermark and Lansner 2003) and are observed
Fig. 5 A Sensitivity analysis.
Individual parameters from
reactions in the pathway are
arranged vertically and
metabolites are arranged
horizontally. Sensitivity values
on a scale from 0 to 1 are
plotted as brown scale boxes at
the intersections of the
respective columns and rows.
High-sensitivity interactions are
white, as indicated by the scale
on the right. Membership of
subpathways and intracellular
locations are indicated by bars
below the ﬁgure. B Correlation
analysis. In this case parameters
are arranged both vertically and
horizontally in the same order
so that the diagonal represents
self-correlation. High
correlations are represented by
light browns
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123in our model for a number of metabolites in this pathway
but not for metabolites outside glycolysis (Fig. 2).
Metabolites showing oscillatory behavior in our simula-
tions do include ATP and ADP, which have been shown to
show coordinated oscillations with glucose-6-phosphate
concentration, calcium concentration, and insulin secretion
(Deeney et al. 2001; Nilsson et al. 1996).
Figure 4 summarizes investigations designed to map the
parameter ranges within which oscillations in the glycol-
ysis pathway are observed in our model. This study iden-
tiﬁes the reactions catalyzed by PFK, PGP, and PK
(reactions v2, v5, and v6 in Fig. 1B) as being particularly
sensitive to parameter changes, while reaction v3 was
particularly insensitive to parameter changes. PFK was
previously identiﬁed as being central to the oscillatory
behavior of this pathway and in particular for modulating
the frequency of oscillations (Westermark and Lansner
2003), but roles for PGP and PK are not well established
and merit further investigation.
We also investigated the global properties of our system.
Choke point analysis (Rahman and Schomburg 2006; Yeh
et al. 2004) identiﬁes reactions that either uniquely con-
sume a speciﬁc substrate or uniquely produce a speciﬁc
product. These are suggested to be particularly sensitive
points in metabolic networks (Yeh et al. 2004). We iden-
tiﬁed six enzymes—GK, PFK, FBA, PGP, PK, and
NDK—as choke points. Five of these are in the glycolysis
pathway, the exception being NDK, suggesting that defects
in the glycolytic pathways are likely to be particularly
deleterious to insulin secretion. Intriguingly, the ﬁrst of
these enzymes, GK, has been found to be mutated in
Maturity-Onset Diabetes of the Young, Type II (MODY 2)
(Vionnet et al. 1992). This raises the possibility that choke
point analysis of particular systems may help identify
candidate genes.
Sensitivity analysis of the glycolysis pathway (Fig. 5A)
indicates that four reactions (v1, v2, v6, and v8) are sen-
sitive to changes in parameter values. Three of the ﬁve
choke points in the glycolysis pathway are also identiﬁed
by sensitivity analysis as important. Reaction v1 is cata-
lyzed by GK, which has been argued to be the primary
control point of glycolysis, i.e., it controls the ﬂux through
the pathway (Matschinsky et al. 1998; Sweet and Mats-
chinsky 1995; Wang and Iynedjian 1997). V2 is the PFK
reaction discussed above, while v6 is the PK reaction,
which is also a choke point on the glycolytic pathway. V8
is the transport of pyruvate into the mitochondrion, whose
effects are notably not correlated with the rest of the gly-
colytic pathway. Outside the glycolytic pathway the model
is relatively resistant to perturbation. However, it does
show signiﬁcant sensitivity in reactions v9 of the TCA
cycle (the ﬁrst step after pyruvate import), v17 of the
NADH:malate aspartate shuttle (the ﬁrst reaction con-
suming imported malate), v24 of the NADH:glycerophos-
phate shuttle (ﬁrst reaction of the respiratory chain), and
v41 and v44 of the pyruvate cycle. Therefore, these may be
important control points in the network.
Taken together, these properties of the GSIS core model
are consistent with previous experimental and modeling
results. It should be emphasized, however, that the con-
centrations of metabolites that our model predicts have not
been tested against experimental evidence. In addition, the
parameters of our model, although based on published
values and producing acceptable qualitative behavior, have
not been optimized as a concerted set. That is, although we
have considered the effects of altering individual parame-
ters on the behavior of the system, we have not explored
parameter space in a consistent way to estimate an optimal
set of values or range of values (e.g., Liebermeister and
Klipp 2005). To do this we will require a set of experi-
mental measurements tailored to the optimization of the
model. The value of generating such a data set will lie in
testing our ability to test the relationships between mea-
sured metabolite concentrations and in the model optimi-
zation per se.
The utility of this model is expected to lie in its ability to
aid our understanding of processes leading to type II dia-
betes (although it may also have other uses). To do this we
will need to extend it to include additional processes, most
notably the generation and detoxiﬁcation of reactive oxy-
gen species, which has recently been implicated in a mouse
model of type II diabetes (Freeman et al. 2006a, 2006b),
and downstream processes leading to the transport of cal-
cium in response to ﬂuctuations in ATP concentration and
the eventual export of insulin.
Comparative aspects
An important consideration of future analysis will be the
comparative aspects of the model. There are two signiﬁcant
issues. First, the structure and parameterization of the
current model draw from a number of different studies that
have been performed either under different conditions or in
different species. Our aim is to build a model that repre-
sents the situation in mouse pancreatic b cells rather than a
generic model. This will require optimization of parame-
ters against experimentally determined concentrations of
metabolites under different glucose concentrations and in
the absence of speciﬁc enzyme activities. This optimization
will bear on our second major issue, which is the ability to
assess the utility of particular mouse models in the human
context. The use of the mouse as a model of human disease
is predicated on the assumption that it represents a good
approximation of the human state. This assumption is
usually based on the relatively close phylogenetic and se-
quence relationship between humans and mice, but sys-
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Studies of this kind will be important from an evolutionary
perspective, i.e., identifying the kinds of changes that can
take place in core parts of metabolism as well as aiding in
the understanding of human disease states. We can foresee
a range of potential studies that could increase an under-
standing of this question. These could range from studies of
the parts list (are all the necessary genes present in both
species? are there gene duplications or deletions in one or
another species? what are the patterns of sequence con-
servation?), to studies of gene expression, splice variation,
protein-protein interaction, and protein modiﬁcation,
through to physiologic comparisons of the properties of the
systems, including metabolomics, and changes (or other-
wise) in the underlying parameters.
Interestingly, we were able to model the effect of one
known interspecies difference in this study: the absence of
malate dehydrogenase (ME) from mouse (but not rat)
pancreatic islets (MacDonald 2002). Deleting ME from our
model increased the cytoplasmic malate concentration, as
might have been expected, and decreased the pyruvate
concentration, but it had no signiﬁcant effect on ATP
concentration or oscillatory behavior. This illustrates the
robustness of the model and also how it can serve as the
basis for analyses of interspecies differences.
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